SciSparc Ltd.
SPRC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001611746
No open-market purchases or sales by SciSparc Ltd. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $296.4K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +5 vs. previous quarter
- 8
- 13F valueReported value at the end of Q2 2026
- $296.4K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding SPRC, Q2 2026
No superinvestor reported holding SPRC at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by SciSparc Ltd. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2026 (view filing) | Jun 1 | 2 days | Shrem ItschakDirector | SSale | −462 | $10.00 | −$4.62K | −4.2%10.6K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in SciSparc Ltd. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HRT Financial LP | 21,235 | $117.0K | 0.00% | +21,235 | New |
| Jane Street Group, LLC | 16,496 | $91.1K | 0.00% | +16,496 | New |
| Citadel Advisors LLC | 11,065 | $61.1K | 0.00% | +11,065 | New |
| UBS Group AG | 4,518 | $24.9K | 0.00% | +1,372+43.6% | Added |
| JPMorgan Chase & Co | 211 | $1.18K | 0.00% | +211 | New |
| Morgan Stanley | 200 | $1.10K | 0.00% | +200 | New |
| SBI Securities Co., Ltd. | 12 | $66 | 0.00% | +11+1,100.0% | Added |
| Royal Bank of Canada | 32 | $0 | 0.00% | +32 | New |